Antineoplastic drugs including those withmanufacturers’ safe handling guidance abiraterone to bexarotene

Table 1. Antineoplastic drugs including those withmanufacturers’ safe handling guidance (MSHG)

http://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138_v3.pdf  

Drug	AHFS classification		MSHG		Reason for listing		Links
abiraterone*		10:00 antineoplastic agents		FDA Pregnancy Category X		DailyMed; DrugBank
ado-trastuzumab emtansine	10:00 antineoplastic agents		yes		Conjugated monoclonal antibody; FDA Pregnancy Category D		DailyMed; DrugBank
altretamine	10:00 antineoplastic agents		yes		FDA Pregnancy category D		DailyMed; DrugBank
amsacrine	NA antineoplastic agents		yes		IARC Group 2B		DrugBank
anastrozole		10:00 antineoplastic agents		FDA Pregnancy category X		DailyMed; DrugBank
arsenic trioxide	10:00 antineoplastic agents		yes		IARC Group 1 carcinogen**; FDA Pregnancy Category D		DailyMed; DrugBank
azacitidine	10:00 antineoplastic agents		yes		IARC Group 2A carcinogen; FDA Pregnancy Category D		DailyMed; DrugBank
bacillus calmette Guerin (BCG)***	80:12 vaccines		yes		See special handling requirements**; FDA Pregnancy Category C		DailyMed
bendamustine	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed;
bexarotene		10:00 antineoplastic agents		FDA Pregnancy Category X		DailyMed; DrugBank